Výsledky vyhledávání - Harry Openshaw
- Zobrazuji výsledky 1 - 17 z 17
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring Autor Harry Openshaw, Brett T. Lund, Ashwin Kashyap, Roscoe Atkinson, Irena Sniecinski, Leslie P. Weiner, Stephen J. Forman
Vydáno 2000Artigo -
9
-
10
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis Autor Imke Metz, Claudia F. Lucchinetti, Harry Openshaw, A. Garcı́a-Merino, Hans Lassmann, Mark S. Freedman, Harry Atkins, Biagio Azzarelli, O Kolár, W. Brück
Vydáno 2007Artigo -
11
Multiple sclerosis conference synopsis and discussion: cellular therapy for treatment of autoimmune diseases (October 2005) Autor Harry Openshaw, Harold Atkins, J. T. Chen, P RM de Bittencourt, Linda M. Griffith, Douglas A. Kerr, Salim Khoury, Paolo A. Muraro, Richard A. Nash, Riccardo Saccardi
Vydáno 2006Artigo -
12
The Immune Response to Herpes Simplex Virus Type 1 Infection in Susceptible Mice Is a Major Cause of Central Nervous System Pathology Resulting in Fatal Encephalitis Autor Patric Lundberg, Chandran Ramakrishna, Jeffrey Brown, J. Michael Tyszka, Mark J Hamamura, David R. Hinton, Susan Kovats, Orhan Nalcioğlu, Kenneth I. Weinberg, Harry Openshaw, Edouard M. Cantin
Vydáno 2008Artigo -
13
Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results Autor James D. Bowen, George H. Kraft, Annette Wundes, Qingbo Guan, Kenneth R. Maravilla, Ted Gooley, Peter A. McSweeney, S.Ž. Pavletić, Harry Openshaw, R Storb, Mark H. Wener, B A McLaughlin, Gretchen Henstorf, RA Nash
Vydáno 2011Artigo -
14
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS Autor Richard A. Nash, George J. Hutton, Michael K. Racke, Uday Popat, Steven M. Devine, Kaitlyn C. Steinmiller, Linda M. Griffith, Paolo A. Muraro, Harry Openshaw, Peter H. Sayre, Olaf Stüve, Douglas L. Arnold, Mark H. Wener, George E. Georges, Annette Wundes, George H. Kraft, James D. Bowen
Vydáno 2017Artigo -
15
Polymyositis as a Manifestation of Chronic Graft-Versus-Host Disease Autor Pablo Parker, N J Chao, Johnathan Ben-Ezra, Neal E. Slatkin, Harry Openshaw, Joyce C. Niland, Charles Linker, Brian Greffe, Ashwin Kashyap, Arturo Molina, Auayporn Nademanee, Margaret O’Donnell, Ina Planás, Khalil Sheibani, Eileen Smith, David S. Snyder, Ricardo Spielberger, Anthony S. Stein, Daniel E. Stepan, Karl G. Blume, Stephen J. Forman
Vydáno 1996Revisão -
16
High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS) Autor Richard A. Nash, George J. Hutton, Michael K. Racke, Uday Popat, Steven M. Devine, Linda M. Griffith, Paolo A. Muraro, Harry Openshaw, Peter H. Sayre, Olaf Stüve, Douglas L. Arnold, Meagan Spychala, K. McConville, Kristina M. Harris, Deborah Phippard, George E. Georges, Annette Wundes, George H. Kraft, James D. Bowen
Vydáno 2014Artigo -
17
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis Autor Richard A. Nash, James D. Bowen, Peter A. McSweeney, Steven Z. Pavletic, Kenneth R. Maravilla, Man-soo Park, Jan Storek, Keith M. Sullivan, Jinan Al-Omaishi, John R. Corboy, John F. DiPersio, George E. Georges, Theodore A. Gooley, Leona Holmberg, C.F. LeMaistre, Kate Ryan, Harry Openshaw, Julie Sunderhaus, Rainer Storb, Joseph R. Zunt, George H. Kraft
Vydáno 2003Artigo
Vyhledávací nástroje:
Související témata
Immunology
Biology
Medicine
Internal medicine
Herpes simplex virus
Multiple sclerosis
Virus
Transplantation
Virology
Genetics
Surgery
Expanded Disability Status Scale
Hematopoietic stem cell transplantation
Interferon
Interferon gamma
Biochemistry
Chemotherapy
Clinical trial
Cytokine
Gastroenterology
Gene
Immune system
Immunosuppression
Neuroscience
Pathology
Stem cell
Adverse effect
Central nervous system
Common Terminology Criteria for Adverse Events
Cyclophosphamide